{
  "id": "646258e1c6cf3100018f154d",
  "title": "3 precanvas Raltegravir test",
  "nickname": "nickname",
  "show_nickname": false,
  "description": null,
  "can_modify_attributes": true,
  "keywords": null,
  "slug": "3-precanvas-raltegravir-test",
  "is_stopping_point": false,
  "resource_type": "page",
  "url": null,
  "html_content": "<p><span style=\"color: rgb(1,25,147);background-color: rgb(255,255,255);font-size: 24px;font-family: Lato, sans-serif;\">On the next page, we'll review the data from THREE Phase I trials. The first is our drug, Raltegravir. We developed the others (Etravirine and PRO 542) just in case Raltegravir was too toxic.</span></p>\n<p></p>\n<p></p>\n<p><span style=\"color: #011993;background-color: rgb(255,255,255);font-size: 16px;font-family: Lato, sans-serif;\"><strong>So, we have THREE choices:</strong></span></p>\n<p></p>\n<p><span style=\"color: rgb(1,25,147);background-color: rgb(255,255,255);font-size: medium;font-family: Lato, sans-serif;\">1) Stick with Raltegravir.</span></p>\n<p></p>\n<p><span style=\"color: rgb(1,25,147);background-color: rgb(255,255,255);font-size: medium;font-family: Lato, sans-serif;\">2) Switch to Etravirine.</span></p>\n<p></p>\n<p><span style=\"color: rgb(1,25,147);background-color: rgb(255,255,255);font-size: medium;font-family: Lato, sans-serif;\">3) Switch to PRO 542.</span></p>\n<p></p>\n<p><span style=\"color: rgb(1,25,147);background-color: rgb(255,255,255);font-size: 24px;font-family: Lato, sans-serif;\"><strong>Click NEXT to see our data!</strong></span></p>\n",
  "created_at": "2023-05-15T16:08:01.395Z",
  "updated_at": "2023-05-15T16:08:01.395Z",
  "polls": [],
  "author": {
    "id": "6362d6e0662a09000121aa47",
    "email": "pratha.avashia@solutelabs.com",
    "first_name": "Pratha",
    "last_name": "Avashia",
    "full_name": "Pratha Avashia",
    "role": "admin",
    "avatar": null,
    "gender": "male",
    "birthday": null
  },
  "media": null,
  "large_canvas_image": null,
  "module_documents": [],
  "discussions": []
}
